Early Experience in Class III Heart Failure Patients was Favorable. V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today the results of its first human implants were published in The Lancet....
Funding to support further development of V-Wave’s Unidirectional Interatrial Shunt for the treatment of Heart Failure. V-Wave Ltd. announced that it has completed a Series B financing of $28M. New investors included Johnson & Johnson Innovation – JJDC Inc.,...
Recent Comments